These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11218239)

  • 1. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study.
    Jeppesen PB; Szkudlarek J; Høy CE; Mortensen PB
    Scand J Gastroenterol; 2001 Jan; 36(1):48-54. PubMed ID: 11218239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study.
    Scolapio JS
    JPEN J Parenter Enteral Nutr; 1999; 23(6):309-12; discussion 312-3. PubMed ID: 10574477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.
    Szkudlarek J; Jeppesen PB; Mortensen PB
    Gut; 2000 Aug; 47(2):199-205. PubMed ID: 10896910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone enhances fat-free mass and glutamine availability in patients with short-bowel syndrome: an ancillary double-blind, randomized crossover study.
    Seguy D; Darmaun D; Duhamel A; Thuillier F; Cynober L; Cortot A; Gottrand F; Messing B
    Am J Clin Nutr; 2014 Sep; 100(3):850-8. PubMed ID: 25080462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study.
    Scolapio JS; Camilleri M; Fleming CR; Oenning LV; Burton DD; Sebo TJ; Batts KP; Kelly DG
    Gastroenterology; 1997 Oct; 113(4):1074-81. PubMed ID: 9322500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human growth hormone and glutamine for patients with short bowel syndrome.
    Wales PW; Nasr A; de Silva N; Yamada J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006321. PubMed ID: 20556765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.
    Seguy D; Vahedi K; Kapel N; Souberbielle JC; Messing B
    Gastroenterology; 2003 Feb; 124(2):293-302. PubMed ID: 12557135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption.
    Jeppesen PB; Høy CE; Mortensen PB
    Am J Clin Nutr; 1999 Jul; 70(1):78-84. PubMed ID: 10393142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial.
    Byrne TA; Wilmore DW; Iyer K; Dibaise J; Clancy K; Robinson MK; Chang P; Gertner JM; Lautz D
    Ann Surg; 2005 Nov; 242(5):655-61. PubMed ID: 16244538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.
    Jeppesen PB; Hartmann B; Thulesen J; Graff J; Lohmann J; Hansen BS; Tofteng F; Poulsen SS; Madsen JL; Holst JJ; Mortensen PB
    Gastroenterology; 2001 Mar; 120(4):806-15. PubMed ID: 11231933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?
    Luo M; Fernández-Estívariz C; Manatunga AK; Bazargan N; Gu LH; Jones DP; Klapproth JM; Sitaraman SV; Leader LM; Galloway JR; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2007; 31(1):1-7. PubMed ID: 17202433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors in short-bowel syndrome patients.
    Jeppesen PB
    Gastroenterol Clin North Am; 2007 Mar; 36(1):109-21, vii. PubMed ID: 17472878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glutamine in short-bowel syndrome.
    Scolapio JS; McGreevy K; Tennyson GS; Burnett OL
    Clin Nutr; 2001 Aug; 20(4):319-23. PubMed ID: 11478829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.
    Byrne TA; Persinger RL; Young LS; Ziegler TR; Wilmore DW
    Ann Surg; 1995 Sep; 222(3):243-54; discussion 254-5. PubMed ID: 7677455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.
    Gu Y; Wu ZH
    World J Gastroenterol; 2002 Aug; 8(4):752-7. PubMed ID: 12174391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.
    Kuppens RJ; Bakker NE; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Donze SH; Festen DA; van Alfen-van der Velden JA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4110-4116. PubMed ID: 27552545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.
    Ellegård L; Bosaeus I; Nordgren S; Bengtsson BA
    Ann Surg; 1997 Jan; 225(1):88-96. PubMed ID: 8998124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.